Drug major Sun Pharma, an Indian multinational pharmaceutical company headquartered in Mumbai, on July 13 announced a slew of changes & reshuffles in the senior management level in its Indian and North American operations.
According to the latest announcement, Abhay Gandhi is the CEO of Sun Pharmas North American business. On the other hand, Kal Sundaram, CEO of North America business & Taro Pharmaceutical Industries Ltd (Taro), will move to India as CEO (India and emerging markets).
- Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma.
- Effective January 2017, Kal Sundaram, currently CEO, North America business & Taro Pharmaceutical Industries Ltd (Taro, will assume the position of CEO, India and emerging markets.